Ayumi Kataoka

Feasibility and safety of intraoperative photodynamic diagnosis using 5-aminolevulinic acid in breast cancer surgery

Haruru Kotani, A. Isogai, Akira Nakakami, Ayumi Kataoka et autres

jp (code pays fourni par la source)

Abstract P4-10-18: Potential predictive biomarkers for a fibroblast growth factor receptor (FGFR) inhibitor: Phase 1b trial of tasurgratinib (E7090) with endocrine therapies (ET) for ER+, HER2+ recurrent/metastatic breast cancer (BC) resistant to CDK4/6 inhibitors

Takahiro Kogawa, Takanori Ishida, Kan Yonemori, Ayumi Kataoka et autres

P212: Evaluation of factors associated with non-pathological complete response in triple negative breast cancer treated with neoadjuvant KEYNOTE-522 chemoimmunotherapy

Maho Kusudo, Akiyo Yoshimura, Masaya Hattori, Haruru Kotani et autres

Utility of a breast biopsy clip and a point marker system in tailored axillary surgery for patients with breast cancer after neoadjuvant chemotherapy

Yuka Endo, Haruru Kotani, Nobuko Tamura, Kiyo Tanaka et autres

jp (code pays fourni par la source)

Safety of a short-term infusion of fosnetupitant in patients with gastrointestinal and breast cancer: a prospective study

Akinobu Nakata, Naoya Hashimoto, Yukiya Narita, Munehiro Wakabayashi et autres

jp (code pays fourni par la source)

Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational study

Ayaka Isogai, Kazuki Nozawa, Akira Nakakami, Rie Komaki et autres

jp (code pays fourni par la source)

Abstract PO4-14-06: Impact of Serum HER2 Extracellular Domain in Metastatic Breast Cancer Patients Treated with Trastuzumab Deruxtecan (T-DXd)

Kazuki Nozawa, Maho Kusudo, Nari Kureyama, Akira Nakakami et autres

jp (code pays fourni par la source)

Abstract PO5-01-01: The comparison of HER2 low and HER2 0 in ductal carcinoma in situ (DCIS) for breast cancer

Nari Kureyama, Maho Kusudo, Akira Nakakami, Rie Komaki et autres

jp (code pays fourni par la source)

Abstract PO4-11-06: Survey of Questionnaires on the Efficacy and Cost of Scalp Cooling Devices in Breast Cancer Patients

Haruru Kotani, Nari Kureyama, Maho Kusudo, Rie Komaki et autres

jp (code pays fourni par la source)

Supraclavicular Irradiation Induces Lymphedema in Breast Cancer Patients Treated with Axillary Lymph Node Dissection and Taxane‐Containing Chemotherapy

Nanae Horisawa, Akiyo Yoshimura, Isao Oze, Masataka Sawaki et autres

jp (code pays fourni par la source)

Single-dose trastuzumab monotherapy achieved pathological complete response (pCR) in a patient with HER2-positive breast cancer: a case report

Ayaka Isogai, Haruru Kotani, Masataka Sawaki, Masaya Hattori et autres

jp (code pays fourni par la source)

ASO Visual Abstract: The Absence of Cancer in the Location of a Breast Tissue Marker After Neoadjuvant Chemotherapy May Predict Pathological Complete Response with High Accuracy—Results from a Phase II Trial

Ayumi Kataoka, Masataka Sawaki, Nanae Horisawa, Haruru Kotani et autres

jp (code pays fourni par la source)